Plasma Osteopontin Is an Independent Prognostic Marker for Head and Neck Cancers We analyzed claims for Medicare-enrolled men older than age 65 years living in Surveillance, Epidemiology, and End ...

Becker’s ASC Review sat down with Randy Whaley, director of business development for United Medical Systems, to tackle a reader’s question about what is needed for an ASC to be able to offer and ...

Pelvic second malignancy occurred twice as often after brachytherapy for prostate cancer as compared with radical prostatectomy, a large retrospective review showed. Second pelvic malignancy -- ...

Brussels, 17 July 2025 – Today marks Brachytherapy Awareness Day, a global initiative to spotlight a cancer treatment that is saving lives with precision: brachytherapy. This advanced form of internal ...